Correlations of creatine and six related pyrimidine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients

Clinical Biochemistry

Volumn 43, Issue 12, 2010, Pages 957-962

  Xia, Jian Fei ^a,b   Hu, Ping ^a   Liang, Qiong Lin ^b   Zou, Ting Ting ^b   Wang, Yi Ming ^b   Luo, Guo An ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Biomarker; Cytidine; Cytosine; Diabetic nephropathy; Thymidine; Type 2 diabetes

Indexed keywords

CREATINE; CYTIDINE; CYTOSINE; DEOXYURIDINE; PYRIMIDINE DERIVATIVE; THYMIDINE; THYMINE; UREA; URIDINE; PYRIMIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PLASMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TANDEM MASS SPECTROMETRY; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; DIABETIC NEPHROPATHY; MIDDLE AGED;

AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; CYTIDINE; CYTOSINE; DEOXYURIDINE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIMIDINES; TANDEM MASS SPECTROMETRY; THYMIDINE; THYMINE; URIDINE;

EID: 77954315136     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.05.013     Document Type: Article

References (22)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025-prevalence, numerical estimates, and projections. Diab Care 1998, 21:1414-1431.
2. Susztak K., Bottinger E.P. Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 2006, 17:361-367.
3. Takezako T., Noda K., Tsuji E., Koga M., Sasaguri M., Arakawa K. Adenosine activates aromatic l-amino acid decarboxylase activity in the kidney and increases dopamine. J Am Soc Nephrol 2001, 12:29-36.
4. Franco M., Tapia E., Martinez F., et al. Adenosine regulates renal nitric oxide production in hypothyroid rats. J Am Soc Nephrol 1999, 10:1681-1688.
5. Cirillo P., Sato W., Reungjui S., Heinig M., Gersch M., Sautin Y., et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol 2006, 17:S165-S168.
6. Pang L.Q., Liang Q.L., Wang Y.M., Li P., Luo G.A. Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy. J Chromatogr B 2008, 869:118-125.
7. Spinazzola A., Marti R., Nishino I., et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002, 277:4128-4133.
8. Soriano F.G., Virag L., Jagtap P., Szabo E., Mabley J.G., Liaudet L., Marton A., Hoyt D.G., Murthy K.G.K., Salzman A.L., Southan G.J., Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001, 7:108-113.
9. Xia J.F., Liang Q.L., Liang X.P., Wang Y.M., H P, Li P., et al. Ultraviolet and tandem mass spectrometry for simultaneous quantification of twenty-one pivotal metabolites in plasma from patients with diabetic nephropathy. J Chromatogr B 2009, 877:1930-1936.
10. Xia J.F., Liang Q.L., H P., Wang Y.M., Li P., Luo G.A. Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients. Clin Biochem 2009, 42:215-220.
11. Ng D.P.K., Krolewski A.S. Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med 2005, 5:509-525.
12. Ritz E. Managing anaemia and diabetes: a future challenge for nephrologists. Nephrol Dial Transplant 2005, 20:21-25.
13. Jones C.A., Krolewski A.S., Rogus J., Xue J.L., Collins A., Warram J.H. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?. Kidney Int 2005, 67:1684-1691.
14. Parving H.H., Harrington J.T., Lewis J., et al. Diabetic nephropathy: prevention and treatment. Kidney Int 2001, 60:2041-2055.
15. Iyengar S.K., Schelling J.R., Sedor J.R. Approaches to understanding susceptibility to nephropathy: from genetics to genomics. Kidney Int 2002, 61:61-67.
16. Seaquist E.R., Goetz F.C., Rich S., Barbosa J. Familial clustering of diabetic kidney-disease-evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989, 320:1161-1165.
17. Costanzi S., Vincenzetti S., Cristalli G., Vita A. Human cytidine deaminase: a three-dimensional homology model of a tetrameric metallo-enzyme inferred from the crystal structure of a distantly related dimeric homologue. J Mol Graph Model 2006, 25:10-16.
18. Stefek M., Tribulova N., Gajdosik A., Gajdosikova A. The pyridoindole antioxidant stobadine attenuates histochemical changes in kidney of streptozotocin-induced diabetic rats. Acta Histochem 2002, 104:413-417.
19. Cleary M.P., Brasel J.A., Greenwood M.R. Developmental changes in thymidine kinase, DNA, and fat cellularity in Zucker rats. Am J Physiol 1979, 236:E508-E513.
20. Sengupta S., Sellers L.A., Matheson H.B., Fan T.P. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol 2003, 139:219-231.
21. Yamada N., Li W., Ihaya A., Kimura T., Morioka K., Uesaka T., et al. Platelet-derived endothelial cell growth factor gene therapy for limb ischemia. J Vasc Surg 2006, 44:1322-1328.
22. Sivridis E., Giatromanolaki A., Touloupidis S., Pasadakis P., Vargemezis V. Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy. Am J Kidney Dis 2003, 41:360-365.